Autolus Therapeutics (AUTL) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $6.2 million.
- Autolus Therapeutics' Accumulated Depreciation & Amortization rose 913.28% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 913.28%. This contributed to the annual value of $7.6 million for FY2024, which is 1506.47% up from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Accumulated Depreciation & Amortization is $6.2 million, which was up 913.28% from $4.1 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $8.5 million for Q4 2021, and its period low was $1.8 million during Q1 2024.
- In the last 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization had a median value of $5.2 million in 2023 and averaged $4.9 million.
- In the last 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization surged by 4948.75% in 2021 and then tumbled by 1702.75% in 2023.
- Quarter analysis of 5 years shows Autolus Therapeutics' Accumulated Depreciation & Amortization stood at $8.5 million in 2021, then fell by 12.25% to $7.4 million in 2022, then dropped by 11.55% to $6.6 million in 2023, then increased by 15.06% to $7.6 million in 2024, then dropped by 18.53% to $6.2 million in 2025.
- Its last three reported values are $6.2 million in Q3 2025, $4.1 million for Q2 2025, and $2.0 million during Q1 2025.